One of the most dreaded feelings for an investor is when the stock they just bought is overvalued, or they missed out on an undervalued opportunity by not acting fast enough.

But what if you had the insights to effectively evaluate a company like AngioDynamics, Inc. before investing? Investing requires a certain perspective to avoid being overly confident in a company or worried about cyclical changes. A smart way to take the guesswork out of knowing when to buy or sell AngioDynamics, Inc.’s stock is to have the right tools and resources as well as a clear monitoring process.

In this article, we go over a few key elements for understanding AngioDynamics, Inc.’s stock price such as:

• Current stock price and volume
• Stock price history
• Upgrades and downgrades from analysts
• Stock price momentum as measured by its relative strength

About AngioDynamics, Inc. (ANGO)

Before we jump into AngioDynamics, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

AngioDynamics, Inc. is a medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options. It operates through two segments, namely Med Tech and Med Device. Its products offerings fall within three global business units: Endovascular Therapies (VIT), Oncology/Surgery (OS) and Vascular Access (VA). Its products include Auryon, Thrombectomy, Peripheral Products (Core), BioFlo, Midlines, Peripherally Inserted Central Catheter (PICC), C3 Wave PICC tip location system, Ports, Dialysis Products, Venous Insufficiency, Microwave Ablation, Radiofrequency Ablation, BioSentry Tract Sealant System, IsoLoc Endorectal Balloon and Alatus Vaginal Balloon Packing System. Its Thrombus Management portfolio includes the AlphaVac System, AngioVac venous drainage system, Thrombolytic catheters and NanoKnife. Its Peripheral Products (Core) include Angiographic Products and Accessories, Drainage Products and Micro Access Kits.

Want to learn more about AngioDynamics, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about AngioDynamics, Inc.. The AAII Stock Evaluator puts a company’s grades, charts, news, financials, valuation, ratios, filings and more at your fingertips.

AngioDynamics, Inc.’s Stock Price as of Market Close

As of March 30, 2023, 4:00 PM CST, AngioDynamics, Inc.’s stock price was $9.10.

AngioDynamics, Inc. is down 27.02% from its previous closing price of $12.47.

During the last market session, AngioDynamics, Inc.’s stock traded between $12.40 and $12.62. Currently, there are 39.49 million shares of AngioDynamics, Inc. stock available for purchase.

Unfortunately, AngioDynamics, Inc.’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

AngioDynamics, Inc. Stock Price History

AngioDynamics, Inc.’s (ANGO) price is currently down 26.49% so far this month.

During the month of March, AngioDynamics, Inc.’s stock price has reached a high of $12.70 and a low of $8.60.

Over the last year, AngioDynamics, Inc. has hit prices as high as $24.87 and as low as $11.33. Year to date, AngioDynamics, Inc.’s stock is down 67.01%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused AngioDynamics, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of March 29, 2023, there were 3 analysts who downgraded AngioDynamics, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate AngioDynamics, Inc.’s financial health and valuation. It is possible for a stock to appear cheap based on one valuation metric but appear expensive on another. It is also possible for one valuation ratio to be associated with outperforming stocks during certain periods of time but not others.

Therefore, AAII developed a composite valuation to help resolve such issues. AAII’s Value Grade analyzes six distinct variables: price-to-sales (P/S) ratio, price-earnings (P/E) ratio, the ratio of enterprise value to earnings before interest, taxes, depreciation and amortization (EV/EBITDA), shareholder yield, price-to-book-value (P/B) ratio and price-to-free-cash-flow (P/FCF) ratio.

AngioDynamics, Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about AngioDynamics, Inc. (ANGO) by visiting AAII Stock Evaluator.

Relative Price Strength of AngioDynamics, Inc.

Relative price strength addresses the relationship between a stock price’s trend and the price trend of the market. This ratio is expressed as a percentage and helps investors understand a company’s momentum as well as its value. You can use relative price strength to select investments that have been outperforming the market or a specific benchmark.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. The weighted four-quarter relative price strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40%, and each of the three previous quarters are given a weighting of 20%.

As of March 29, 2023, AngioDynamics, Inc. has a weighted four-quarter relative price strength of -8.97%, which translates to a Momentum Score of 29 and is considered to be Weak.

Want to learn more about how AngioDynamics, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

AngioDynamics, Inc. Stock Price: Bottom Line

As of March 30, 2023, AngioDynamics, Inc.’s stock price is $9.10, which is down 27.02% from its previous closing price.

At AAII, we stress that investors should never buy or sell a stock solely based on its stock price. Past returns do not guarantee future performance. Therefore, you should consider multiple ratios, fundamentals and analytics before making a decision. Whether you decide it’s a good time to buy or sell AngioDynamics, Inc.’s stock based on its stock price forecast is ultimately up to you.

It’s important to understand that stock prices are driven by a variety of factors, but ultimately the price at any given moment is due to the supply and demand in the market. Stock price overviews, like the one you just read, only give you a small snapshot of a company’s performance, value and momentum.

By becoming an A+ Investor subscriber, you will have full access to analytics, grades, stock screens, commentary and more so you can invest with confidence.